Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.
Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory
distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory
illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of
COVID-19 are dominated by respiratory symptoms, some patients show severe kidney
abnormalities. Acute kidney injury (AKI) has been identified as an independent risk factor
for in-hospital mortality. The present study aims to investigate the incidence of AKI and
renal recovery of inpatients diagnosed with COVID-19.
Inclusion Criteria:
1) Patients with COVID-19 diagnosed by World Health Organisation (WHO) criteria
Exclusion Criteria:
1. Patients aged less than 18 years
2. Patients with stage 4 chronic kidney disease (baseline estimated glomerular filtration
rate <30 ml/min/1.73 m2)
3. Patients receiving maintenance dialysis
4. Recipients of solid-organ transplantation
University Hospital Giessen and Marburg, Giessen
Giessen, Hessen, Germany
Werner Seeger, MD, Study Director
University Hospital Giessen and Marburg, Giessen